Novel Roadside Handheld Devices Offer Convenience of Drug Detection

An alarming rate of deaths caused due to drink and drive scenarios are increasingly becoming a matter of concern for government authorities worldwide. Thus, innovations in the healthcare industry are generating incremental opportunities for companies in the roadside drug testing devices market. For instance, in December 2019, Abbott-a global leader in medical devices announced the launch of the SoToxa™ Mobile Test System, which is acquiring global recognition. Novel roadside drug testing devices are gaining importance to combat drug-impaired driving and ensure road safety.

Companies in the roadside drug testing devices market are increasing their production capabilities to develop handheld devices. This is evident since handheld modality segment is estimated for exponential growth during the forecast period and the global roadside drug testing devices market is expected to reach a value of ~US$ 924 Mn by the end of 2027. Stakeholders in law enforcement are using oral fluid swabs that are inserted in handheld analyzers to detect marijuana and other drugs within minutes.

roadside drug testing devices market infographic

To know the scope of our report Get a Sample on Roadside Drug Testing Devices Market     

Driving Simulators Help in Conducting Successful Clinical Trials

As suggested by the Swinburne University of Technology, drug users are apparently surpassing the number of alcohol consumers in Australia, resulting in high rates of fatal crashes. Hence, companies in the roadside drug testing devices market should tap opportunities in Australia to increase the uptake of detection devices. Likewise, companies in the market for roadside drug testing devices are collaborating with researchers to increase R&D in psychology and neurosciences to ascertain if drivers under the influence of cannabis are more likely to meet with an accident, as compared to alcohol consumers.

With the introduction of driving simulators, companies in the roadside drug testing devices market are able to conduct better analysis of cognitive behavior and psychomotor functioning of individuals through the help of clinical trials. Companies in the market for roadside drug testing devices are gaining important insights through research findings carried out as a result of collaborations between universities and medical institutes.

Get a glimpse of the in-depth analysis through our Report Brochure

Breathalyzers with Nanotechnology Sensors a Gold Standard for Detection of THC

Breathalyzers are becoming increasingly mainstream in the detection of alcohol in the roadside drug testing devices market. However, there is a growing need for breathalyzers that are also capable of detecting marijuana. Hence, researchers in the market for roadside drug testing devices are increasing R&D to develop novel breathalyzers that detect THC. For instance, an interdisciplinary team at the University of Pittsburgh, developed a breathalyzer using nanotechnology sensors that detect THC. Thus, innovative breathalyzers are increasingly becoming the gold standard for THC detection and manufacturers should collaborate with researchers to innovate in devices. This trend has supported the exponential growth of THC among other substance types in the roadside drug testing devices market.

Companies in the roadside drug testing devices market are increasing research in developing breathalyzers using carbon nanotubes and nanotechnology sensors to meet requirements of mass spectrometry. This trend is prominent in the U.S. since legalization of recreational marijuana has raised concerns about the enforcement of DUI (Driving Under the Influence) laws in the region.

Innovations in THC Breathalyzers Generate Incremental Opportunities for Manufacturers

Since THC drugs segment is anticipated for exponential growth in the market for roadside drug testing devices, manufacturers are introducing breakthrough innovations that are a novel addition to the cannabis detection sector. For instance, Cannabix Technologies- a supplier of drug detection tools has announced that its scientific team has come up with a proprietary method-Field asymmetric waveform ion mobility spectrometry (FAIMS) to detect THC. Such innovations have contributed toward the modest of the roadside drug testing devices market, which is expected to expand at a CAGR of ~4% during the forecast period. Hence, manufacturers are focusing on innovating breathalyzers using high-field ion mobility and mass spectrometry.

Companies in the roadside drug testing devices market are developing lightweight devices that are user-friendly and store numerous samples. They are increasing efforts to develop devices that are capable of detecting extremely low quantities of THC analytes. Thus, innovative breathalyzers are increasingly replacing conventional breath analyzing techniques. 

roadside drug testing devices market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The roadside drug testing devices market is projected for exponential growth in North America. Lack of efficient DUI laws in the U.S. are fueling the demand for drug testing devices. Manufacturers are increasing efforts to meet the demand for breath analyzers that can detect extremely low quantities of THC analytes.

Increased research spending has become the key focus point of companies in the market landscape. However, incidences of false positives from poppy seeds and tea in drug testing devices act as barriers for market growth. Hence, manufacturers should develop devices that can differentiate between drugs or alcohol and food items that are merely in the system of an individual.

Roadside Drug Testing Devices Market: Overview

  • According to Transparency Market Research’s latest research report on the global roadside drug testing devices market for the historical period of 2017–2018 and the forecast period of 2019–2027, increase in the number of drug and alcohol abusers and adoption of rapid test devices for screening or identification of drug and alcohol are anticipated to drive the global roadside drug testing devices market during the forecast period
  • According to the report, the global roadside drug testing devices market was valued at US$ 0.65 Bn in 2018. It is projected to expand at a CAGR of ~4% from 2019 to 2027.

Technological Advancements in Roadside Drug Testing Devices to Propel Market: A Key Driver

  • Roadside drug testing devices have already been adopted by the police force, with the introduction of a large number of new breathalyzer devices
  • Recent advancements by providers of drug, alcohol, and disease-testing products offer police with a robust set of roadside testing tools for the detection of alcohol and drug classes such as amphetamine, benzodiazepines, cannabis (THC), cocaine, methamphetamine, and opiates
  • New tests, such as paper spray mass spectrometry, analyze molecules in a fingerprint. As the body metabolizes a drug, it excretes molecules, which can (apparently) be detected in fingerprints by using the mass spectrometry method. The method works even after the hands are washed. Hence, there is no ‘coming clean’ with a quick trip to the sink. Researchers report 99% of accuracy rate by using this method.
  • Increase in the burden of drug and alcohol abuse and technological advancements have resulted in the adoption of portable roadside drug testing devices. Thus, rise in the demand for portable or handheld roadside drug testing devices is expected to propel the global roadside drug testing devices market during the forecast period.

Large Target Population

  • Increase in the number of drug and alcohol abusers across the world is expected to provide significant opportunities to test providers and manufacturers of drug abuse test products in the near future. According to the United Nations Office of Drug and Crime, over 5% of the global population aged between 15 and 64 years uses illicit drugs. Moreover, nearly 32.4 million people worldwide use pharmaceutical opioids and opiates such as opium or heroin.
  • According to the Centers for Disease Control and Prevention (CDC), around 4.7% of people aged 16 years or above in the U.S. are reported to be driving under the influence of marijuana and 0.9% are reported to be driving under the influence of illicit drugs other than marijuana.
  • Rise in target population and increase in government initiatives to control road accidents and fatalities in various countries are likely to drive the global roadside drug testing devices market during the forecast period

Inaccurate Results to Hamper Roadside Drug Testing Devices Market

  • Concerns about the efficacy and efficiency of roadside drug testing devices have increased over the last few years. For instance, in a study, which included over 300 Norway-based drivers who were tested for impairment by using both the oral device as well as the blood sample, it was found that the ratio of false-positive results generated by the device to findings of the blood sample was 14.5% for cannabis and 87.1% for cocaine.
  • Inaccurate results (false-positive or false-negative results) associated with roadside drug testing devices are projected to restrain the global roadside drug testing devices market during the forecast period

Roadside Drug Testing Devices Market: Competition Landscape

  • This report profiles major players operating in the global roadside drug testing devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The roadside drug testing devices market is moderately fragmented with the presence of a few large-scale players in the global market and some small-scale players in regional markets. The top four to five players hold a major share of the global roadside drug testing devices market.
  • Prominent players operating in the global roadside drug testing devices market are 
    • Drägerwerk AG & Co. KgaA
    • Abbott Laboratories
    • Oranoxis Inc.
    • CareHealth America
    • MAVAND Solutions GmbH
    • Pacific Data Systems Pty Ltd
    • Securetec, and UriTox, LLC

Roadside Drug Testing Devices Market: Key Developments

  • Key players operating in the global roadside drug testing devices market are engaged in the development and approval of new products, mergers and acquisitions, and collaborations. Major developments by key players operating in the global market are likely to fuel the global roadside drug testing devices market in the next few years. Some of the key developments in the global roadside drug testing devices market are as follows:
    • In October 2017, Abbott Laboratories acquired Alere, Inc. for approximately US$ 4.5 Bn. The acquisition strengthened the company’s product portfolio in the point of care testing devices and solutions segment. SoToxa, formerly known as the Alere DDS2 mobile test system, is able to generate test results indicating the presence of certain drugs in just five minutes. SoToxa is currently being used by law enforcement agencies in countries across the world including Canada, Germany, Spain, the U.K., and the U.S.
    • In September 2018, Securetec launched WipeAlyser, a mobile analysis device for use with the DrugWipe rapid drug screening test. DrugWipe itself is a highly precise saliva test for quick and safe detection of up to seven drug types.
    • In June 2019, Securetec developed the DrugWipe 2S saliva test for buprenorphine and methadone. The two active substances i.e. buprenorphine and methadone were used successfully to treat drug addiction.
  • The report on the global roadside drug testing devices market discusses individual strategies, followed by company profiles of manufacturers of roadside drug testing devices. The ‘Competition Landscape’ section has been included in the report to provide readers with a dashboard view and company market share analysis of key players operating in the global roadside drug testing devices market.

Roadside Drug Testing Devices Market - Scope of the Report

TMR’s report on the global roadside drug testing devices market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global roadside drug testing devices market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global roadside drug testing devices market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global roadside drug testing devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global roadside drug testing devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global roadside drug testing devices market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global roadside drug testing devices market.

The report delves into the competitive landscape of the global roadside drug testing devices market. Key players operating in the global roadside drug testing devices market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global roadside drug testing devices market that have been profiled in this report.

Key Questions Answered in Roadside Drug Testing Devices Market Report

  • What is the scope of growth of companies in the global roadside drug testing devices market?
  • What will be the Y-o-Y growth of the global roadside drug testing devices market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global roadside drug testing devices market?
  • Will North America continue to be the most profitable market for roadside drug testing devices providers?
  • Which factors will hamper the growth of the global roadside drug testing devices market during the forecast period?
  • Which are the leading companies in the global roadside drug testing devices market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global roadside drug testing devices market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred by analysts during the production of the global roadside drug testing devices market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who have contributed to the production of TMR’s study on the global roadside drug testing devices market as primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from the roadside drug testing devices market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global roadside drug testing devices market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on the prospects of the global roadside drug testing devices market more reliably and accurately.

Roadside Drug Testing Devices Market – Segmentation

Substance

Drugs

  • Tetrahydrocannabinol (THC)
  • Cocaine
  • Amphetamine
  • Benzodiazepines
  • Opioids
  • Others

Alcohol

Sample Type

Saliva

Sweat

Urine

Others

Modality

Handheld

Standalone

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Roadside Drug Testing Devices Market

Buy Now